한글목차

세계의 소화관 스텐트 시장 규모는 2024년 5억 1,275만 달러로 평가되었으며, 2030년까지 연평균 복합 성장률(CAGR) 5.38%를 기록하면서 안정적으로 성장할 것으로 예측되고 있습니다.

소화관 스텐트는 식도, 위, 장, 담도와 같은 소화관의 개통을 유지하는 데 사용되는 중요한 의료기기입니다. 주로 금속이나 플라스틱으로 구성된 이러한 스텐트는 암이나 염증, 기타 소화관 질환에 의한 폐색이나 협착으로 고민하는 환자에게 저침습 치료 선택지를 제공합니다. 시장은 기술적 진보 및 임상 용도의 확대와 함께 진화하고 있으며, 시장 역학의 변화에 적응하기 위한 업계들의 전략적 전환도 진행되고 있습니다. 예를 들어 2024년 3월에는 올림푸스주식회사가 한국의 스텐트 제조업체 인수 계획에서 철수하면서 세계 의료기기 업계의 전략적 중점 변화가 나타났습니다.

시장 성장 촉진요인

위장 질환 유병률 상승

주요 시장 과제

합병증의 위험

주요 시장 동향

생분해성 스텐트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 소화관 스텐트 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 제품 유형별(담관 스텐트, 결장 스텐트, 십이지장 스텐트, 식도 스텐트, 췌장 스텐트)
  • 용도별(담도질환, 대장암, 위암, 염증성 장질환, 기타)
  • 지역별
  • 기업별(2024년)
• 제품 시장 맵
  • 제품 유형별
  • 용도별
  • 지역별

제6장 북미의 소화관 스텐트 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 소화관 스텐트 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 소화관 스텐트 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 소화관 스텐트 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 소화관 스텐트 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 최근 동향
• 합병 및 인수
• 제품 출시

제13장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Boston Scientific Corporation
• Cook Group Inc
• Becton Dickinson & Co Ltd
• CONMED Corporation
• Cantel Medical LLC
• ELLA-CS, sro
• Hobbs Medical Inc.
• Merit Medical Systems, Inc.
• Olympus Corp
• Diagmed Healthcare Ltd

제15장 전략적 제안

제16장 기업 소개 및 면책사항

영문목차

The Global Gastrointestinal Stents Market was valued at USD 512.75 million in 2024 and is projected to grow steadily, registering a CAGR of 5.38% through 2030. Gastrointestinal stents are vital medical devices used to maintain the patency of gastrointestinal pathways, including the esophagus, stomach, intestines, and biliary tract. Constructed primarily from metal or plastic, these stents offer minimally invasive treatment options for patients suffering from obstructions or strictures caused by cancer, inflammation, or other gastrointestinal disorders. The market is evolving with technological advancements and expanding clinical applications, alongside strategic shifts by industry players to adapt to changing market dynamics. For example, in March 2024, Olympus Corporation withdrew from its proposed acquisition of a South Korean stent manufacturer, signaling a shift in strategic focus within the global medical device landscape.

Key Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The growing global burden of gastrointestinal disorders is a major factor propelling demand for gastrointestinal stents. Conditions such as colorectal cancer, strictures, and functional gastrointestinal disorders (FGIDs) are increasingly common, leading to higher demand for effective interventions. According to the National Library of Medicine (2021), over 40% of the global population experiences FGIDs, significantly impacting patient well-being and placing greater strain on healthcare systems. This widespread prevalence underscores the need for accessible and effective solutions like stent placements to restore normal gastrointestinal function and alleviate symptoms.

Key Market Challenges

Risk of Complications

Despite their clinical utility, gastrointestinal stents come with inherent risks, including stent migration, perforation, and infections. These complications can compromise patient safety and require additional interventions, thus posing a challenge for clinicians. Achieving the optimal balance between therapeutic benefit and potential complications remains a critical consideration for healthcare professionals in stent selection and placement.

Key Market Trends

Biodegradable Stents

A notable trend gaining traction in the gastrointestinal stents market is the development and clinical adoption of biodegradable stents. Unlike traditional metal or plastic stents, biodegradable variants are designed to naturally degrade over time, eliminating the need for removal procedures. These stents reduce the risk of long-term complications and can minimize patient follow-up, offering a more patient-friendly and cost-effective alternative, particularly in temporary applications.

Key Market Players

• Boston Scientific Corporation
• Cook Group Inc
• Becton Dickinson & Co Ltd
• CONMED Corporation
• Cantel Medical LLC
• ELLA-CS, s.r.o.
• Hobbs Medical Inc.
• Merit Medical Systems, Inc.
• Olympus Corp
• Diagmed Healthcare Ltd

Report Scope:

In this report, the Global Gastrointestinal Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Stents Market, By Product Type:

• Biliary Stent
• Colonic Stent
• Duodenal Stent
• Esophageal Stent
• Pancreatic Stent

Gastrointestinal Stents Market, By Application:

• Biliary Disease
• Colorectal Cancer
• Stomach Cancer
• Inflammatory Bowel Disease
• Others

Gastrointestinal Stents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastrointestinal Stents Market.

Available Customizations:

Global Gastrointestinal Stents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Stents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 5.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product Type
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Gastrointestinal Stents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 6.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gastrointestinal Stents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Gastrointestinal Stents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Gastrointestinal Stents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application

7. Europe Gastrointestinal Stents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 7.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gastrointestinal Stents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Gastrointestinal Stents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
  • 7.3.3. France Gastrointestinal Stents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Gastrointestinal Stents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Gastrointestinal Stents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Gastrointestinal Stents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 8.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Gastrointestinal Stents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Gastrointestinal Stents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
  • 8.3.3. India Gastrointestinal Stents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Gastrointestinal Stents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Gastrointestinal Stents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application

9. South America Gastrointestinal Stents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 9.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Gastrointestinal Stents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Gastrointestinal Stents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Gastrointestinal Stents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Gastrointestinal Stents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
  • 10.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Gastrointestinal Stents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Gastrointestinal Stents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Gastrointestinal Stents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Boston Scientific Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Product Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cook Group Inc
• 14.3. Becton Dickinson & Co Ltd
• 14.4. CONMED Corporation
• 14.5. Cantel Medical LLC
• 14.6. ELLA-CS, s.r.o.
• 14.7. Hobbs Medical Inc.
• 14.8. Merit Medical Systems, Inc.
• 14.9. Olympus Corp
• 14.10. Diagmed Healthcare Ltd

15. Strategic Recommendations

16. About Us & Disclaimer